Echo IQ’s EchoSolv AS gains FDA approval—AI-powered solution to tackle underdiagnosed Aortic Stenosis
Sydney-based AI medical technology company, Echo IQ Limited, has achieved a significant breakthrough with the US Food and Drug Administration (FDA) clearance for its EchoSolv AS software, positioning itself to transform Aortic Stenosis (AS) detection across the United States. This clearance not only permits the company to market its advanced solution in the United States […]